PMID- 31827620 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220411 IS - 1755-8166 (Print) IS - 1755-8166 (Electronic) IS - 1755-8166 (Linking) VI - 12 DP - 2019 TI - Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation. PG - 47 LID - 10.1186/s13039-019-0460-2 [doi] LID - 47 AB - BACKGROUND: Jumping translocations (JTs) are rare chromosome rearrangements characterized by re-localization of one donor chromosome to multiple recipient chromosomes. Here, we describe an acute myeloid leukemia (AML) that progressed from myelodysplastic syndrome (MDS) in association with acquisition of 1q JTs. The sequence of molecular and cytogenetic changes in our patient may provide a mechanistic model for the generation of JTs in leukemia. CASE PRESENTATION: A 68-year-old man presented with pancytopenia. Bone marrow aspirate and biopsy showed a hypercellular marrow with multilineage dysplasia, consistent with MDS, with no increase in blasts. Karyotype and MDS fluorescence in situ hybridization (FISH) panel were normal. Repeat bone marrow aspirate and biopsy after 8 cycles of azacitidine, with persistent pancytopenia, showed no changes in morphology, and karyotype was again normal. Myeloid mutation panel showed mutations in RUNX1, SRSF2, ASXL1, and TET2. Three years after diagnosis, he developed AML with myelodysplasia-related changes. Karyotype was abnormal, with unbalanced 1q JTs to the short arms of acrocentric chromosomes 14 and 21, leading to gain of 1q. CONCLUSIONS: Our patient had MDS with pathogenic mutations of the RUNX1, SRSF2, ASXL1, and TET2 genes and developed 1q JTs at the time of progression from MDS to AML. Our data suggest that the formation of 1q JTs involves multiple stages and may provide a mechanistic model for the generation of JTs in leukemia. CI - (c) The Author(s). 2019. FAU - Lee, Ina AU - Lee I AD - 1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 FAU - Gudipati, Mary A AU - Gudipati MA AD - 1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 FAU - Waters, Elizabeth AU - Waters E AD - 1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 FAU - Duong, Vu H AU - Duong VH AD - 2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 AD - University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD USA. FAU - Baer, Maria R AU - Baer MR AD - 2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 AD - University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD USA. FAU - Zou, Ying AU - Zou Y AUID- ORCID: 0000-0003-2787-1917 AD - 1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD USA. ISNI: 0000 0001 2175 4264. GRID: grid.411024.2 AD - University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD USA. AD - 4Department of Pathology, Johns Hopkins University, 1812 Ashland Ave., Suite 200, Room 221, Baltimore, MD 21205 USA. ISNI: 0000 0001 2171 9311. GRID: grid.21107.35 LA - eng PT - Case Reports DEP - 20191119 PL - England TA - Mol Cytogenet JT - Molecular cytogenetics JID - 101317942 PMC - PMC6862801 OTO - NOTNLM OT - Acute myeloid leukemia OT - Jumping translocations OT - Myelodysplastic syndrome OT - TET2 COIS- Competing interestsThe authors declare that they have no competing interests. EDAT- 2019/12/13 06:00 MHDA- 2019/12/13 06:01 PMCR- 2019/11/19 CRDT- 2019/12/13 06:00 PHST- 2019/10/15 00:00 [received] PHST- 2019/11/01 00:00 [accepted] PHST- 2019/12/13 06:00 [entrez] PHST- 2019/12/13 06:00 [pubmed] PHST- 2019/12/13 06:01 [medline] PHST- 2019/11/19 00:00 [pmc-release] AID - 460 [pii] AID - 10.1186/s13039-019-0460-2 [doi] PST - epublish SO - Mol Cytogenet. 2019 Nov 19;12:47. doi: 10.1186/s13039-019-0460-2. eCollection 2019.